Literature DB >> 31391605

Complication of an artificial urethral sphincter in the treatment of a urethral sphincter mechanism incompetence.

Lindsay A Parker1, Sherisse Sakals1.   

Abstract

A 5-year-old, 39-kg spayed female mixed breed dog was treated for urinary sphincter mechanism incompetence with an artificial urethral sphincter (AUS). The dog was continent for 2 months, but then dramatic incontinence abruptly recurred. Imaging indicated that there was a leak in the cuff of the AUS. The AUS was replaced and continence was re-established.

Entities:  

Mesh:

Year:  2019        PMID: 31391605      PMCID: PMC6625174     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  5 in total

1.  Use of a percutaneously controlled urethral hydraulic occluder for treatment of refractory urinary incontinence in 18 female dogs.

Authors:  Rachael L Currao; Allyson C Berent; Chick Weisse; Philip Fox
Journal:  Vet Surg       Date:  2013-01-08       Impact factor: 1.495

2.  Outcome after placement of an artificial urethral sphincter in 27 dogs.

Authors:  Lauren Reeves; Christopher Adin; Mary McLoughlin; Kathleen Ham; Dennis Chew
Journal:  Vet Surg       Date:  2012-11-19       Impact factor: 1.495

3.  Clinical, urodynamic, and histologic effects of urethral intussusception in clinically normal dogs.

Authors:  S G Bertrand; J R Bellah; P E Ginn
Journal:  Am J Vet Res       Date:  1998-07       Impact factor: 1.156

4.  Long-term efficacy of a percutaneously adjustable hydraulic urethral sphincter for treatment of urinary incontinence in four dogs.

Authors:  Scott A Rose; Christopher A Adin; Gary W Ellison; Colin W Sereda; Linda L Archer
Journal:  Vet Surg       Date:  2009-08       Impact factor: 1.495

5.  Urodynamic effects of a percutaneously controlled static hydraulic urethral sphincter in canine cadavers.

Authors:  Christopher A Adin; James P Farese; Alan R Cross; Mary K Provitola; Jeffrey S Davidson; Hope Jankunas
Journal:  Am J Vet Res       Date:  2004-03       Impact factor: 1.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.